Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Makoto Endo"'
Autor:
Eisuke Kobayashi, Suguru Fukushima, Shintaro Iwata, Fumihiko Nakatani, Makoto Nakagawa, Issay Kitabayashi, Masaya Sekimizu, Makoto Endo, Akira Kawai, Hitoshi Ichikawa, Akihiko Yoshida
Publikováno v:
Journal of Orthopaedic Science. 27:1315-1322
Mutant isocitrate dehydrogenase (IDH) in chondrosarcoma produces the oncometabolite 2-hydroxyglutarate (2-HG) and contributes to malignant progression, and is therefore a potential therapeutic target for chondrosarcoma. Robust historical control data
Autor:
Makoto Endo, Hidetaka Yamamoto, Shin Ishihara, Kengo Kawaguchi, Yoshihiro Matsumoto, Yuichi Yamada, Yasuharu Nakashima, Kenichi Kohashi, Yoshihiro Ito, Toshifumi Fujiwara, Izumi Kinoshita, Yuko Kakuda, Yousuke Susuki, Takeo Yamamoto, Nokitaka Setsu, Masato Yoshimoto, Yoshinao Oda, Yu Toda, Takeshi Iwasaki
Publikováno v:
Modern Pathology. 35:640-648
In rare cases, giant cell tumor of bone (GCTB) can undergo primary or secondary malignant transformation to malignant giant cell tumor of bone (MGCTB), but the details of the molecular alterations are still unclear. The present study aimed to elucida
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 35:132-137
Autor:
Tom Wei-Wu Chen, Herbert H. Loong, Sze Huey Tan, Alex K.C. Leung, Richard Quek, Chih Chi Chang, Angela Pang, Myo Myint Maw, Takeshi Hirose, Makoto Endo, Akira Kawai, Mark E. Puhaindran, Virote Sriuranpong, Siyamol Mingmalairak, Mohamad Farid, Jeffrey C.H. Chan, Wei Lin Goh, Roger K.C. Ngan
Publikováno v:
Cancer Science
Angiosarcoma (AS) is a rare disease with a dismal prognosis. The treatment landscape and prognostic factors for advanced AS, including locally advanced, unresectable, and metastatic disease remain elusive. The Asian Sarcoma Consortium is an internati
Publikováno v:
Expert Review of Anticancer Therapy. 20:893-900
Soft-tissue sarcoma (STS) denotes a group of rare and highly heterogeneous malignant tumors of mesenchymal origin. Accurate histological diagnosis is critical for selecting appropriate treatment. Complete tumor resection is the primary treatment for
Publikováno v:
J Thorac Dis
BACKGROUND: Spread through air spaces (STAS) is reportedly a significant risk factor for recurrence and a prognostic factor in patients with non-small cell lung cancer (NSCLC), especially after sublobar resection. Because wedge resection (WR) is asso
Autor:
Hiroaki Hiraga, Makoto Endo, Takafumi Ueda, Akihiko Matsumine, Toru Hiruma, Nobuhito Araki, Hideo Morioka, Tsukasa Yonemoto, Toshiyuki Kunisada, Kazato Goda, Shunji Takahashi, Akira Kawai, Hideshi Sugiura, Mitsuru Takahashi
Publikováno v:
Cancer Medicine, Vol 9, Iss 11, Pp 3656-3667 (2020)
Cancer Medicine
Cancer Medicine
The time course of the response to each drug is important to avoid inappropriate termination of treatment by misjudging tumor progression; however, little is known about soft tissue sarcoma (STS) regarding this matter. This study aimed to perform a t
Autor:
Yoshihiro Matsumoto, Hitoshi Kusaba, Hiroshi Ariyama, Ryuji Yasumatsu, Eishi Baba, Junji Kishimoto, Makoto Endo, Shohei Moriyama, Toshifumi Fujiwara, Nokitaka Setsu, Koichi Akashi, Takahiro Wakasaki, Kenji Tsuchihashi, Kenta Nio, Yasuharu Nakashima, Mitsuhiro Fukata, Kyoko Yamaguchi, Mamoru Ito, Tomoyasu Yoshihiro, Keisuke Taguchi
Publikováno v:
International Journal of Surgery Oncology. 5:e891-e896
Tyrosine kinase inhibitors (TKI) work against various types of cancer by inhibiting angiogenic signaling. Little is understood about the incidence, characteristics, and risk factors associated with thromboembolism induced by TKI in routine clinical p
Autor:
Yoshihiro Matsumoto, Yu Toda, Nokitaka Setsu, Kenichiro Yahiro, Suguru Fukushima, Tomoya Matsunobu, Atsushi Kimura, Makoto Endo, Hidetaka Yamamoto, Makoto Nakagawa, Yoshinao Oda, Toshifumi Fujiwara, Eijiro Shimada, Masaya Kanahori, Yasuharu Nakashima
BackgroundDenosumab is a game-changing drug for giant cell tumor of bone (GCTB); however, its clinical biomarker in terms of post-administration ossification of the tumors has not been elucidated. The aims of this study were to investigate the relati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45409477904fc059535cebe4d1bf0eac
https://doi.org/10.21203/rs.3.rs-738278/v1
https://doi.org/10.21203/rs.3.rs-738278/v1
Autor:
Makoto Endo, Yuichi Yamada, Hiroshi Furukawa, Yoshinao Oda, Hidetaka Yamamoto, Yu Toda, Yuki Tateishi, Kenichi Kohashi, Yoshihiro Ito, Masato Yoshimoto, Yosuke Susuki, Yasuharu Nakashima, Izumi Kinoshita, Shin Ishihara, Kengo Kawaguchi, Taro Mori
Publikováno v:
Virchows Archiv : an international journal of pathology. 479(6)
Malignant peripheral nerve sheath tumor (MPNST) is a very aggressive peripheral nerve sheath-derived sarcoma, which is one of the most difficult tumors to diagnose due to its wide spectrum of histological findings and lack of specific immunohistochem